Fairvoy Private Wealth’s AbbVie ABBV Stock Holding History

Fairvoy Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$503K	Hold	1,997	–	–	0.1%	139
2026 Q1	$434K	Hold	1,997	–	–	0.1%	146
2025 Q4	$456K	Sell	1,997 -20	-1%	-$4.56K	0.1%	126
2025 Q3	$467K	Sell	2,017 -110	-5%	-$22.4K	0.11%	125
2025 Q2	$395K	Buy	2,127 +170	+9%	+$31.6K	0.1%	129
2025 Q1	$410K	Sell	1,957 -4	-0.2%	-$778	0.11%	126
2024 Q4	$348K	Buy	+1,961	New	+$361K	0.09%	135

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Fairvoy Private Wealth's ABBV Position: Q2 2026 in Review

Fairvoy Private Wealth held its AbbVie (ABBV) position steady in Q2 2026 at 1,997 shares worth $503K. The position accounts for 0.1% of the portfolio, ranked #139.

Fairvoy Private Wealth first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,043 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Fairvoy Private Wealth held 1,997 shares of AbbVie worth $503K as of Q2 2026.
Fairvoy Private Wealth left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.1% of Fairvoy Private Wealth's portfolio in Q2 2026, its #139 holding.
Fairvoy Private Wealth first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
1,043 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fairvoy Private Wealth's 13F filing for Q2 2026, filed 17 Jul 2026.